Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pliant Therapeutics (PLRX) Other Non-Current Liabilities (2019 - 2021)

Pliant Therapeutics (PLRX) has disclosed Other Non-Current Liabilities for 3 consecutive years, with $756000.0 as the latest value for Q3 2021.

  • On a quarterly basis, Other Non-Current Liabilities rose 25100.0% to $756000.0 in Q3 2021 year-over-year; TTM through Sep 2021 was $756000.0, a 25100.0% increase, with the full-year FY2020 number at $866000.0, up 8560.0% from a year prior.
  • Other Non-Current Liabilities was $756000.0 for Q3 2021 at Pliant Therapeutics, down from $804000.0 in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $866000.0 in Q4 2020 to a low of $3000.0 in Q3 2020.
  • A 3-year average of $525428.6 and a median of $756000.0 in 2021 define the central range for Other Non-Current Liabilities.
  • Biggest YoY gain for Other Non-Current Liabilities was 25100.0% in 2021; the steepest drop was 99.01% in 2021.
  • Pliant Therapeutics' Other Non-Current Liabilities stood at $10000.0 in 2019, then soared by 8560.0% to $866000.0 in 2020, then dropped by 12.7% to $756000.0 in 2021.
  • Per Business Quant, the three most recent readings for PLRX's Other Non-Current Liabilities are $756000.0 (Q3 2021), $804000.0 (Q2 2021), and $835000.0 (Q1 2021).